Law360 | Alston & Bird Nabs Former FDA Associate Chief Counsel

Alston & Bird has formed a working group to advise clients on the business and legal implications of the COVID-19 coronavirus.

Cathy Burgess is quoted on the dramatic decline in the Food and Drug Administration’s foreign inspections amid COVID-19.

Cathy Burgess, partner in Alston & Bird’s Health Care Group and leader of the firm’s FDA Compliance & Enforcement Team, has been recognized by The National Law Journal in its third annual list of professionals identified as agents of change in health care and life sciences law.

Alston & Bird health care attorneys have authored several chapters in a new edition of a book aimed at helping the rapidly evolving pharmaceutical industry master the governing principles and compliance standards for Current Good Manufacturing Practices (CGMPs).

Marc Scheineson explains why a lawsuit against the Food and Drug Administration for delaying a rule regulating new tobacco products is unlikely to be accepted by the court.